home / stock / otlk / otlk articles

OTLK Articles, Outlook Therapeutics Inc. - From 11/12/23

Stock Information
Company Name: Outlook Therapeutics Inc.
Stock Symbol: OTLK
Market: NASDAQ
Website: outlooktherapeutics.com
Menu
OTLK OTLK Quote OTLK Short OTLK News OTLK Articles OTLK Message Board
Get OTLK Alerts

News, Short Squeeze, Breakout and More Instantly...
OUTLOOK ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Outlook Therapeutics, Inc. and Encourages Investors to Contact the Firm | Benzinga

NEW YORK, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds invest...
DEADLINE ALERT for SEDG, BCLI, BCLYF/BCS, and OTLK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders | Benzinga

LOS ANGELES, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on ...

OUTLOOK DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Outlook To Contact Him Directly To Discuss Their Options | Benzinga

If you purchased or acquired securities in Outlook between December 29, 2022 and August 29, 2023 and would like to discuss your legal rights, call...

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Outlook Therapeutics, Inc. (OTLK) Investors of a Class Action Lawsuit and Upcoming Deadline | Benzinga

NEW YORK, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Outlook Therapeutics, Inc. ("Outlook" or the...
OTLK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Outlook Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit | Benzinga

SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Outlook Therapeutics...

ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – OTLK | Benzinga

NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action laws...

Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Outlook Therapeutics, Inc. (BCS) | Benzinga

SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action lawsuit on behalf of persons...
OUTLOOK THERAPEUTICS, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Outlook Therapeutics, Inc. (NASDAQ: OTLK) | Benzinga

NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK)?...

Class Action Lawsuit Filed Against Outlook Therapeutics, Inc. (OTLK) on Behalf of Investors – Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm | Benzinga

ATLANTA, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed aga...

Pomerantz Law Firm Announces the Filing of a Class Action Against Outlook Therapeutics, Inc. and Certain Officers – OTLK | Benzinga

NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Outlook Therapeutics, Inc...
Previous 10 Next 10